ABBV idea ABBV NEEDS to start holding support now if it wants to continue higher. it is buyable as of now, BUT, if we start breaking the swing high (labeled with a red line) this will be in trouble and could see a drop down to sub $120.
ABBV trade ideas
AbbVie Poised to Expand in Neurobiology with Cerevel AcquisitionPharmaceutical giant AbbVie Inc. is considering enhancing its neurobiological portfolio as it finalises the acquisition of neurobiotech firm Cerevel Therapeutics. Initially announced in December 2023 for 8.7 billion USD, the acquisition was primarily focused on Cerevel's experimental schizophrenia drug, Emraclidine. This drug represents a new class of psychiatric medications that have recently sparked increased interest within the pharmaceutical industry.
The deal's prospects have been further boosted by promising clinical trial results from Cerevel's Parkinson's disease drug, reinforcing the strategic fit of this acquisition for AbbVie. The company's broad portfolio diversification, consistent dividend payments, and stable positive cash flow make AbbVie's securities attractive to investors.
Examining the technical analysis of AbbVie Inc. (NYSE: ABBV) for potential investment opportunities:
On the Daily (D1) timeframe, the stock has formed a support level at 161.50 USD and resistance at 170.55 USD. The stock is currently in a downtrend within a channel and is nearing the upper boundary of this trend. A breakout above the downtrend line could lead to a break of the resistance and initiate an uptrend. Conversely, if the stock breaks below the support level, the next target could be 151.50 USD.
For traders, purchasing the stock if it breaks the resistance at 170.55 USD could make sense, with a short-term price target set at 182.10 USD. For those looking at a medium-term investment, holding a long position with a target of up to 195.00 USD can be considered.
—
Ideas and other content presented on this page should not be considered as guidance for trading or an investment advice. RoboMarkets bears no responsibility for trading results based on trading opinions described in these analytical reviews.
The material presented and the information contained herein is for information purposes only and in no way should be considered as the provision of investment advice for the purposes of Investment Firms Law L. 87(I)/2017 of the Republic of Cyprus or any other form of personal advice or recommendation, which relates to certain types of transactions with certain types of financial instruments.
Risk Warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69.88% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
ABBV - cautious with this dipNYSE:ABBV is a great company. It's part of my long-term portfolio and is one that I've been able to manage well with technical analysis.
I am not adding unless I see price fall to 155 or until we get to August/September where it hits its seasonal low. This drawdown has risk of continuation for a number of reasons:
Momentum was falling as price was rising. Drawdowns after this type of divergence usually have more challenging recoveries.
The candle body on 4/4 is the spread in price to go against the long term uptrend. These are strong warnings of a reversal.
It lost the YTD AVWAP and is struggling to hold the VWAP anchored to the November low. If this area fails we'll see investors begin to sell to protect profit.
There is a large airgap down to 155., which is the lowest that price can fall while remaining in a primary uptrend.
A fibonacci time zone drawn at momentum crossovers in April 2023 and June 2023 gives a view of an overall price cycle. The next time zone is August 2024, which aligns to a season
$ABBV bull flagABBV looks like it is bull flagging.
Calls for June look good, cover ER with stop on daily close below 176
☀️ABBV BUY☀️Entry Price (173.97) : Chosen based on Fibonacci retracement levels, suggesting a potential point to buy or enter the stock, expecting the price to increase from this level.
Take Profit (179.97) : Set near a Fibonacci extension or resistance level, indicating a target price to sell and secure profits before the stock might pull back.
Stop Loss (171.97) : Established to limit potential losses, placed below a key Fibonacci or support level, indicating where to exit the trade if the price unexpectedly drops.
Current Price (178.88) : The stock is presently above the entry point but hasn't reached the profit target, suggesting the possibility of a minor pullback before moving higher towards the target.
This strategy uses Fibonacci levels to identify strategic entry, exit, and profit-taking points, reflecting anticipated price movements based on historical patterns and market psychology.
☀️ABBV BUY☀️
💲Entry Price : 173.97
💰TP1 : 179.97
🏳️SL : 171.97
ABBV touch the upper zoneLow volume near resistance zone. There could be a break in the next few days
Abbvie Might Be About To Crack All Time HighsHey everyone!
Today we're taking a look at Abbvie, NYSE:ABBV a popular U.S. pharmaceutical stock.
In the chart above, we've combined a momentum view with a support & resistance framework to point out high points and low points of the recent range ABBV has been trading in.
In combination with the momentum indicator, it appears as though the chances of a break of all time highs is likely.
For reference, here's what the chart looks like without the momentum overlay:
For our part, we like the idea of buying this stock into highs, while trailing the daily 3/3 pivot points:
This should provide a solid amount of upside, while limiting risk significantly.
If you like ABBV from a fundamental standpoint, then trailing the larger weekly 10/10 pivots is also an option, down to $135:
That's 50 points of risk, but for a longer term hold it appears probable that a 1:1 kick scenario should pay out nicely.
Good luck out there!
Want more high-quality trade ideas? Follow us below. ⬇️⬇️
ABBV AbbVie Options Ahead of EarningsIf you haven`t bought the dip on ABBV:
Then analyzing the options chain and the chart patterns of ABBV AbbVie prior to the earnings report this week,
I would consider purchasing the 160usd strike price Calls with
an expiration date of 2024-3-15,
for a premium of approximately $7.55.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Abbvie Inc. LongCiao,
pretty distinguishable balance between supply and demand for Abbvie. Looking to trade in the range, stop losses below the potential stop hunt -levels.
Good luck with the shopping!
ABBV Bullish Flag SetupStrong bull flag continuation pattern forming here on ABBV. There's big gap fill potential above supply zone so expect resistance break to get us to 159 quickly. Gains after that should be slower but expecting an $8-9 move above current supply zone based on the height of the flag pole. Please see chart for more details.
ABBV long ideaHi Traders!
Let's take a look at ABBV on the daily timeframe. The price has been forming the descending channel pattern for the last months. The price is at the downsloping resistance line right now. We expect the price to fall from here down to the downsloping support line and bounce up from the strong horizontal support. We would enter long when the price reach the support.
What do you think? Let us know in the comments!
Abbvie Inc. (ABBV): Financial & Competitive AnalysisAbout Abbvie:
Abbvie Inc. (NYSE: ABBV) stands as a prominent player in the pharmaceutical industry, known for its diverse product portfolio and strategic market positioning. This analysis delves into AbbVie's financial health, growth projections, and its competitive landscape.
Financial Highlights:
With a robust revenue of $58.054 billion in 2022 and a consistent increase in gross profit, AbbVie showcases financial strength. The company maintains strong operational cash flows, indicating efficient management.
Growth Projections:
Over the next three years, AbbVie is expected to see a compounded annual growth rate (CAGR) of approximately 6-8%. This projection is based on the company's ongoing product development and market expansion strategies.
Competitive Positioning:
Johnson & Johnson (JNJ): A diversified healthcare giant with a broader range of products.
Pfizer Inc. (PFE): Known for its innovative drugs and recent success in vaccines.
Merck & Co Inc (MRK): Strong in oncology and vaccines.
Eli Lilly and Co (LLY): A leader in diabetes and cancer treatments.
Conclusion:
AbbVie, with its focus on research and development in high-demand therapeutic areas, is well-positioned to compete effectively in the dynamic pharmaceutical industry. The expected growth and strong financials make it an attractive consideration for investors.
Disclaimer:
This analysis is for informational purposes and should not be considered investment advice. Investors should conduct their own research or consult with a financial advisor before making investment decisions.
ABBVIE Short term buy signal.ABBV is on a bearish 1D technical outlook (RSI = 39.987, MACD = -1.990, ADX = 42.078) but is quite possibly forming a short term bottom as the 1D RSI rebounded from an oversold level (under 30.00), while the MACD is close to forming a Bullish Cross. Every time those two conditions were fulfilled simultaneously inside the 1 year Channel Down, the price was a buy. Go long and target a similar LH trendline to early 2023 (TP = 153.00).
## If you like our free content follow our profile to get more daily ideas. ##
## Comments and likes are greatly appreciated. ##
ABBV AbbVie Options Ahead of EarningsIf you haven`t bought the dip on ABBV here:
Then analyzing the options chain and the chart patterns of ABBV AbbVie prior to the earnings report this week,
I would consider purchasing the 147usd strike price Calls with
an expiration date of 2023-11-17,
for a premium of approximately $3.30.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Looking forward to read your opinion about it.
ABBV range 153-146ABBV is taking a nap
Above 153 we can see a bullish sentiment
Below 146 we can see a bearish trend
As I can see, there are more probability of going up
But, what do you think?
ABBV Long Entry We are in a bull flag, appropriate long entry would be at the bottom of the downward channel.
$ABBV: Huge reward to risk long entryNYSE:ABBV offers a very low risk daily trend signal entry, which can evolve into a weekly mean reversion move towards $153.80 by mid September or sooner.
Stop loss area should be a bit below the daily uptrend mode @ 135.35 (where buyers accumulated shares at between June 30th and July 13th), as this level should hold as support and prevent the stock from going much lower if retested.
Daily trend only anticipates a roughly 2 week long uptrend, but over time it might form new trend signals indicating continuation. If your original bottom entry at the reversal here is never stopped you could just let this run till mid September and land a huge reward to risk profit.
Best of luck!
Cheers,
Ivan Labrie.
ABBV AbbVie Options Ahead of EarningsAnalyzing the options chain and the chart patterns of ABBV AbbVie prior to the earnings report this week,
I would consider purchasing the 150usd strike price Calls with
an expiration date of 2023-9-15,
for a premium of approximately $2.46.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Looking forward to read your opinion about it.
CUPI can't find a clear handle but I put a green line where I see the closest support level.
You may see a clear handle which is a level of support. Mid cup can also be a level of support.
Cup patterns use the depth of the cup to calculate targets.
No recommendation
$ABBV with a bullish outlook following its earnings #StocksThe PEAD projected a bullish outlook for NYSE:ABBV after a positive under reaction following its earnings release placing the stock in drift A with an expected accuracy of 66.67%.
ABBVIE Any pull-back is a buy opportunity.AbbVie Inc. (ABBV) is having the strongest 1D candle since October 13 2022, hitting the 1D MA200 (orange trend-line) for the first time in almost three months. The long-term pattern is a Channel Down and this one is the bullish leg to a new Lower High.
The 1D RSI has breached into overbought (70.00>) territory so any pull-back is a buy, even on the current levels. Our medium-term target is the 0.786 Fibonacci retracement level (158.50) similar to what happened on the December 09 2022 High.
-------------------------------------------------------------------------------
** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! **
-------------------------------------------------------------------------------
💸💸💸💸💸💸
👇 👇 👇 👇 👇 👇
ABBV looks good for me to buy now As it shown on the chart NYSE:ABBV it is a good zone to open a new position because it is trading near by a daily support
My Stop Loss 4 Hours close lower than the support zone 133$
What do you think about ABBV ?
